68 related articles for article (PubMed ID: 7628916)
1. Immunosuppressive and antiproliferative effects of somatostatin analog SMS 201-995.
Radosević-Stasić B; Trobonjaca Z; Lucin P; Cuk M; Polić B; Rukavina D
Int J Neurosci; 1995 Apr; 81(3-4):283-97. PubMed ID: 7628916
[TBL] [Abstract][Full Text] [Related]
2. Experiences with evaluation of immunosuppressive activity of alpha-globulin fraction of human blood plasma.
Bednarík T; Cajthamlová H; Lostický C; Novák J; Soucek J
Czech Med; 1984; 7(2):100-6. PubMed ID: 6204824
[TBL] [Abstract][Full Text] [Related]
3. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human peripheral blood lymphocytes IL-10 BY SMS 201-995.
Casnici C; Lattuada D; Franco P; Cattaneo L; Marelli O
J Neuroimmunol; 2004 Apr; 149(1-2):210-6. PubMed ID: 15020082
[TBL] [Abstract][Full Text] [Related]
5. A novel murine model for the assessment of human CD2-related reagents in vivo.
Ding Y; Qin L; Yang Q; Punch JD; Fox DA; Hochman PS; Bromberg JS
J Immunol; 1996 Sep; 157(5):1863-9. PubMed ID: 8757303
[TBL] [Abstract][Full Text] [Related]
6. [Influence of isoniazid on selected parameters of immunological response].
Demkow U; Zielonka TM; Radomska D; Chorostowska-Wynimko J; Skopińska-Rózewska E
Pol Merkur Lekarski; 2000 Jan; 7(43):27-30. PubMed ID: 10765648
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro.
Pawlikowski M; Kunert-Radek J; Winczyk K
Cytobios; 1997; 89(358-359):183-7. PubMed ID: 9418016
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8Rbeta interactions.
Singh UP; Singh S; Boyaka PN; McGhee JR; Lillard JW
J Leukoc Biol; 2004 Dec; 76(6):1240-7. PubMed ID: 15356099
[TBL] [Abstract][Full Text] [Related]
9. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
Teplán I
Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
[TBL] [Abstract][Full Text] [Related]
10. Human tumor gangliosides inhibit murine immune responses in vivo.
Li R; Villacreses N; Ladisch S
Cancer Res; 1995 Jan; 55(2):211-4. PubMed ID: 7812945
[TBL] [Abstract][Full Text] [Related]
11. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro immunosuppressive effects of benzo[k]fluoranthene in female Balb/c mice.
Jeon TW; Jin CH; Lee SK; Lee DW; Hyun SH; Kim GH; Jun IH; Lee BM; Yum YN; Kim JK; Kim OH; Jeong TC
J Toxicol Environ Health A; 2005 Dec; 68(23-24):2033-50. PubMed ID: 16326422
[TBL] [Abstract][Full Text] [Related]
13. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
[TBL] [Abstract][Full Text] [Related]
14. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
15. Activation and preferential expansion of rat cytotoxic (CD8) T cells in vitro and in vivo with a bispecific (anti-TCR alpha/beta x anti-CD2) F(ab')2 antibody.
Tutt AL; Reid R; Wilkins BS; Glennie MJ
J Immunol; 1995 Sep; 155(6):2960-71. PubMed ID: 7673714
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
[TBL] [Abstract][Full Text] [Related]
17. Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma.
Demanet C; Brissinck J; Leo O; Moser M; Thielemans K
Cancer Res; 1994 Jun; 54(11):2973-8. PubMed ID: 8187084
[TBL] [Abstract][Full Text] [Related]
18. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
Yoshida M; Takeuchi M; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
Leibnitz RR; Lipsky PE; Thiele DL
J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
